ID: ALA5270691

Max Phase: Preclinical

Molecular Formula: C10H14N2O2

Molecular Weight: 194.23

Associated Items:

Representations

Canonical SMILES:  CC(C)NC(=O)c1cc(N)ccc1O

Standard InChI:  InChI=1S/C10H14N2O2/c1-6(2)12-10(14)8-5-7(11)3-4-9(8)13/h3-6,13H,11H2,1-2H3,(H,12,14)

Standard InChI Key:  RDXNAXNSFWHSCK-UHFFFAOYSA-N

Associated Targets(Human)

Arachidonate 5-lipoxygenase 6568 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 194.23Molecular Weight (Monoisotopic): 194.1055AlogP: 1.11#Rotatable Bonds: 2
Polar Surface Area: 75.35Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.06CX Basic pKa: 4.42CX LogP: 1.34CX LogD: 1.33
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.49Np Likeness Score: -0.71

References

1. Meshram MA, Bhise UO, Makhal PN, Kaki VR..  (2021)  Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.,  225  [PMID:34479036] [10.1016/j.ejmech.2021.113804]

Source